Joint (JYNT) vs Research Frontiers (REFR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Joint (JYNT) has outperformed Research Frontiers (REFR) over the past year, losing 18.9% versus a loss of 61.8%. Over five years, REFR leads with a -70.4% price change compared with -91.0% for JYNT. Joint is the larger company by market cap ($100.7 million vs $21.7 million), about 4.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | JYNT | REFR |
|---|---|---|
| Share price | $7.12 | $0.6224 |
| Market cap | $100.70M | $21.70M |
| 1-day change | -1.11% | -8.95% |
| YTD return | -18.35% | -47.82% |
| 1-year return | -18.91% | -61.81% |
| 5-year return | -90.95% | -70.41% |
| P/E ratio (TTM) | 50.86 | — |
| Forward P/E | 10.71 | — |
| EPS (TTM) | $0.14 | $-0.06 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.67 | $2.70 |
| 52-week low | $7.00 | $0.34 |
| Distance from 52-week high | -33.27% | -76.95% |
| Analyst consensus | buy | — |
| Avg. price target upside | +40.45% | — |
| Average volume | 78.31K | 1.66M |
| Shares outstanding | 14.14M | 34.87M |
| Employees | 202 | 5 |
| Sector | Healthcare | Technology |
| Industry | Medical Care Facilities | Electronic Components |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Joint is about 4.6 times larger than Research Frontiers by market value ($100.70M vs $21.70M).
- JYNT has outperformed REFR by 42.9 percentage points over the past year.
- The two companies sit in different sectors: Joint in Healthcare and Research Frontiers in Technology.
About Joint
JYNT stock →The Joint Corp. operates and is a franchisor and operator of chiropractic clinics in the United States.
Healthcare · Medical Care Facilities · 202 employees
About Research Frontiers
REFR stock →Research Frontiers Incorporated, together with other subsidiary, engages in the development and marketing of technology and devices to control the flow of light worldwide. It develops and licenses suspended particle device (SPD-Smart) light-control technology to companies that manufacture and market the SPD-Smart chemical emulsion, light-control film made from the chemical emulsion, the light-control panels made by laminating the film, and electronics to power end-products incorporating the film, as well as lamination services for and the end-products, such as windows, skylights, and sunroofs.
Technology · Electronic Components · 5 employees
JYNT vs REFR FAQ
Which is bigger, Joint or Research Frontiers?
Joint (JYNT) is larger, with a market capitalization of $100.70M compared with $21.70M for Research Frontiers (REFR).
Which stock has performed better over the past year, JYNT or REFR?
JYNT returned -18.91% over the past 12 months, compared with -61.81% for REFR (price return, excluding dividends). Past performance does not predict future results.
Are Joint and Research Frontiers in the same industry?
No. Joint is in the Healthcare sector, while Research Frontiers is in Technology.